Poliseno et al. reported that the depletion of PTEN and/or PTENP1 increased the proliferation of DU145 prostate cancer cells, compared to administration of non-targeting siRNA, by an amount that was statistically significant (Figure 2F in the 2010 paper). The gene discussed is PTENP1; the disease is Familial prostate cancer.